OBJECTIVES: HIV-1 infection of the CNS is associated with impairment of CBF and neurocognitive function, and accelerated signs of aging. As normal aging is associated with rarefaction of the cerebral vasculature, we set out to examine chronic viral effects on the cerebral vasculature. METHODS: DOX-inducible HIV-1 Tat-tg and WT control mice were used. Animals were treated with DOX for three weeks or five to seven months. Cerebral vessel density and capillary segment length were determined from quantitative image analyses of sectioned cortical tissue. In addition, movement of red blood cells in individual capillaries was imaged in vivo using multiphoton microscopy, to determine RBCV and flux. RESULTS: Mean RBCV was not different between Tat-tg mice and age-matched WT controls. However, cortical capillaries from Tat-tg mice showed a significant loss of RBCV heterogeneity and increased RBCF that was attributed to a marked decrease in total cortical capillary length (35-40%) compared to WT mice. CONCLUSIONS: Cerebrovascular rarefaction is accelerated in HIV-1 Tat-transgenic mice, and this is associated with alterations in red cell blood velocity. These changes may have relevance to the pathogenesis of HIV-associated neurocognitive disorders in an aging HIV-positive population.
OBJECTIVES:HIV-1 infection of the CNS is associated with impairment of CBF and neurocognitive function, and accelerated signs of aging. As normal aging is associated with rarefaction of the cerebral vasculature, we set out to examine chronic viral effects on the cerebral vasculature. METHODS:DOX-inducible HIV-1Tat-tg and WT control mice were used. Animals were treated with DOX for three weeks or five to seven months. Cerebral vessel density and capillary segment length were determined from quantitative image analyses of sectioned cortical tissue. In addition, movement of red blood cells in individual capillaries was imaged in vivo using multiphoton microscopy, to determine RBCV and flux. RESULTS: Mean RBCV was not different between Tat-tgmice and age-matched WT controls. However, cortical capillaries from Tat-tgmice showed a significant loss of RBCV heterogeneity and increased RBCF that was attributed to a marked decrease in total cortical capillary length (35-40%) compared to WT mice. CONCLUSIONS: Cerebrovascular rarefaction is accelerated in HIV-1Tat-transgenic mice, and this is associated with alterations in red cell blood velocity. These changes may have relevance to the pathogenesis of HIV-associated neurocognitive disorders in an aging HIV-positive population.
Authors: Jean-Pierre Louboutin; Beverly A S Reyes; Lokesh Agrawal; Elisabeth J Van Bockstaele; David S Strayer Journal: Eur J Neurosci Date: 2011-11-17 Impact factor: 3.386
Authors: Andy Y Shih; Pablo Blinder; Philbert S Tsai; Beth Friedman; Geoffrey Stanley; Patrick D Lyden; David Kleinfeld Journal: Nat Neurosci Date: 2012-12-16 Impact factor: 24.884
Authors: Andrew D Redd; Djeneba Dabitao; Jay H Bream; Blake Charvat; Oliver Laeyendecker; Noah Kiwanuka; Tom Lutalo; Godfrey Kigozi; Aaron A R Tobian; Jordyn Gamiel; Jessica D Neal; Amy E Oliver; Joseph B Margolick; Nelson Sewankambo; Steven J Reynolds; Maria J Wawer; David Serwadda; Ronald H Gray; Thomas C Quinn Journal: Proc Natl Acad Sci U S A Date: 2009-04-08 Impact factor: 11.205
Authors: Edoardo Vicenzini; Maria Chiara Ricciardi; Marta Altieri; Francesco Puccinelli; Novella Bonaffini; Vittorio Di Piero; Gian Luigi Lenzi Journal: Eur Neurol Date: 2007-06-12 Impact factor: 1.710
Authors: Aron M Troen; Melissa Shea-Budgell; Barbara Shukitt-Hale; Donald E Smith; Jacob Selhub; Irwin H Rosenberg Journal: Proc Natl Acad Sci U S A Date: 2008-08-18 Impact factor: 11.205
Authors: Crystal R Leibrand; Jason J Paris; M Said Ghandour; Pamela E Knapp; Woong-Ki Kim; Kurt F Hauser; MaryPeace McRae Journal: Neurosci Lett Date: 2017-01-03 Impact factor: 3.046
Authors: Arianna R S Lark; Lindsay K Silva; Sara R Nass; Michael G Marone; Michael Ohene-Nyako; Therese M Ihrig; William D Marks; Viktor Yarotskyy; A Rory McQuiston; Pamela E Knapp; Kurt F Hauser Journal: Cell Mol Neurobiol Date: 2022-06-13 Impact factor: 5.046